Integrated Care Pathway in Oncology (PASSION)
Integrated Care Pathway in Oncology (PASSION)
A centralized unit for integrated management of care pathway in Oncology has been created.
 This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy,
 imaging, oncologist...).

 The aim of this study is to assess the delay between the first appointment with the
 oncologist and the beginning of the antitumoral treatment, and therefore evaluate the
 efficacy of the care pathway unit.

 The second aim is to assess the satisfaction of patients and health care teams.
PASSION is a french monocentric study.

 For the retrospective cohort, patient will be selected through the use of data warehouse
 available on the HEGP.

 For the prospective cohort, patient will be included according to the selection criteria.

 Each patient will be followed up during 6 month and a satisfaction questionnaire will be
 completed at 1 month and 4 month of the first administration of anti-tumor therapy.

 For both cohort, clinical-anatomo-biological data will be collected through the use of data
 warehouse available on the HEGP.
Inclusion Criteria:

 -  Histologically proven : colon, gastric, pancreatic, prostate, bladder, breast,
 thoracic, or ovarian cancer

 -  First appointment for cancer care at the Hôpital Européen Georges Pompidou

 -  Intravenous antitumoral treatment

 Exclusion Criteria:

 -  Medical care non covered by social welfare

 -  Radiochemotherapy

 -  Death in the 6 months following first oncological appointment or absence of medical
 care in the year following the first oncological appointment